Trade Summary

3 days ago, Watanabe Todd, serving as See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 37,349 shares at $25.18 per share, for a total transaction value of $940,528.00. Following this transaction, Watanabe Todd now holds 1,019,091 shares of ARQT.

This sale represents a 4.00% decrease in Watanabe Todd's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, March 2, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, March 3, 2026, 1 day after the trade was made.

Arcutis Biotherapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.